● Recruiting

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

Condition: Prostate Cancer · Hormone Sensitive Prostate Cancer · Metastatic Tumor · Sponsor: Santa Chiara Hospital

PhaseN/A

Planned participants3000

Who can joinMale, N/A to no upper limit

Healthy volunteersNo

About this study

The aim of this observational study is to evaluate the clinical outcomes of treatment with docetaxel, ARTA (alone or in combination) or with radiotherapy on the primary tumor for mCSPC, in an unselected population, in clinical practice

This description comes directly from the study's public registry record.

Talk to the study team

Orazio Caffo, MD · +390461904416 · orazio.caffo@apss.tn.it

Always discuss trial participation with your own doctor first.

Locations (3)

Azienda Ospedaliera San Luigi	Orbassano, Torino, Italy	Recruiting
Istituto Oncologico Veneto	Padova, Italy	Recruiting
Santa Chiara Hospital	Trento, Italy	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06473259